These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 25224811

  • 21. The absence of sympathoexcitation during the development of hypertension in Cyp1a1 Ren-2 transgenic rats.
    Zicha J, Hojná S, Kopkan L, Červenka L, Vaněčková I.
    Physiol Res; 2019 Apr 30; 68(2):329-334. PubMed ID: 31037948
    [Abstract] [Full Text] [Related]

  • 22. Similar renoprotection after renin-angiotensin-dependent and -independent antihypertensive therapy in 5/6-nephrectomized Ren-2 transgenic rats: are there blood pressure-independent effects?
    Kujal P, Chábová VČ, Vernerová Z, Walkowska A, Kompanowska-Jezierska E, Sadowski J, Vaňourková Z, Husková Z, Opočenský M, Skaroupková P, Schejbalová S, Kramer HJ, Rakušan D, Malý J, Netuka I, Vaněčková I, Kopkan L, Cervenka L.
    Clin Exp Pharmacol Physiol; 2010 Dec 30; 37(12):1159-69. PubMed ID: 20880190
    [Abstract] [Full Text] [Related]

  • 23. Endothelin receptor blockade does not affect blood pressure or angiotensin II levels in CYP1A1-Ren-2 transgenic rats with acutely induced hypertension.
    Vanourková Z, Kramer HJ, Erbanová M, Bäcker A, Cervenka L, Husková Z, Chábová VC, Tesar V, Dvorák P, Malý J, Vanecková I.
    Vascul Pharmacol; 2009 Dec 30; 50(5-6):194-9. PubMed ID: 19563737
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Transient induction of ANG II-dependent malignant hypertension causes sustained elevation of blood pressure and augmentation of the pressor response to ANG II in CYP1A1-REN2 transgenic rats.
    Howard CG, Mullins JJ, Mitchell KD.
    Am J Med Sci; 2010 Jun 30; 339(6):543-8. PubMed ID: 20375689
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Enhancement of renin and prorenin receptor in collecting duct of Cyp1a1-Ren2 rats may contribute to development and progression of malignant hypertension.
    Prieto MC, Williams DE, Liu L, Kavanagh KL, Mullins JJ, Mitchell KD.
    Am J Physiol Renal Physiol; 2011 Feb 30; 300(2):F581-8. PubMed ID: 21068087
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Soluble epoxide hydrolase inhibitor trans-4-[4-(3-adamantan-1-yl-ureido)-cyclohexyloxy]-benzoic acid is neuroprotective in rat model of ischemic stroke.
    Shaik JS, Ahmad M, Li W, Rose ME, Foley LM, Hitchens TK, Graham SH, Hwang SH, Hammock BD, Poloyac SM.
    Am J Physiol Heart Circ Physiol; 2013 Dec 01; 305(11):H1605-13. PubMed ID: 24043255
    [Abstract] [Full Text] [Related]

  • 34. Meloxicam fails to augment the reno-protective effects of soluble epoxide hydrolase inhibition in streptozotocin-induced diabetic rats via increased 20-HETE levels.
    Katary MM, Pye C, Elmarakby AA.
    Prostaglandins Other Lipid Mediat; 2017 Sep 01; 132():3-11. PubMed ID: 27596333
    [Abstract] [Full Text] [Related]

  • 35. Soluble epoxide hydrolase in the generation and maintenance of high blood pressure in spontaneously hypertensive rats.
    Koeners MP, Wesseling S, Ulu A, Sepúlveda RL, Morisseau C, Braam B, Hammock BD, Joles JA.
    Am J Physiol Endocrinol Metab; 2011 Apr 01; 300(4):E691-8. PubMed ID: 21266668
    [Abstract] [Full Text] [Related]

  • 36. Renal nitric oxide synthase and antioxidant preservation in Cyp1a1-Ren-2 transgenic rats with inducible malignant hypertension.
    Cunningham MW, Sasser JM, West CA, Milani CJ, Baylis C, Mitchell KD.
    Am J Hypertens; 2013 Oct 01; 26(10):1242-9. PubMed ID: 23764378
    [Abstract] [Full Text] [Related]

  • 37. Role of haem oxygenase in the renoprotective effects of soluble epoxide hydrolase inhibition in diabetic spontaneously hypertensive rats.
    Elmarakby AA, Faulkner J, Pye C, Rouch K, Alhashim A, Maddipati KR, Baban B.
    Clin Sci (Lond); 2013 Oct 01; 125(7):349-59. PubMed ID: 23611540
    [Abstract] [Full Text] [Related]

  • 38. Gradual hypertension induction in middle-aged Cyp1a1-Ren2 transgenic rats produces significant impairments in spatial learning.
    Willeman MN, Chawla MK, Zempare MA, Biwer LA, Hoang LT, Uprety AR, Fitzhugh MC, De Both M, Coleman PD, Trouard TP, Alexander GE, Mitchell KD, Barnes CA, Hale TM, Huentelman M.
    Physiol Rep; 2019 Mar 01; 7(6):e14010. PubMed ID: 30916484
    [Abstract] [Full Text] [Related]

  • 39. Two pharmacological epoxyeicosatrienoic acid-enhancing therapies are effectively antihypertensive and reduce the severity of ischemic arrhythmias in rats with angiotensin II-dependent hypertension.
    Červenka L, Husková Z, Kopkan L, Kikerlová S, Sedláková L, Vaňourková Z, Alánová P, Kolář F, Hammock BD, Hwang SH, Imig JD, Falck JR, Sadowski J, Kompanowska-Jezierska E, Neckář J.
    J Hypertens; 2018 Jun 01; 36(6):1326-1341. PubMed ID: 29570510
    [Abstract] [Full Text] [Related]

  • 40. Chronic direct renin inhibition with aliskiren prevents the development of hypertension in Cyp1a1-Ren2 transgenic rats with inducible ANG II-dependent hypertension.
    Huang L, Howard CG, Mitchell KD.
    Am J Med Sci; 2012 Oct 01; 344(4):301-6. PubMed ID: 22261625
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.